| Line 72: |
Line 72: |
| | ==Drugs in This Group== | | ==Drugs in This Group== |
| | | | |
| − | | + | {| border="1" cellpadding="7" |
| | + | |-style="background:#B0E0E6; color:black" |
| | + | !'''Compound''' |
| | + | !'''Relative glucocorticoid activity''' |
| | + | !'''Relative mineralocorticoid activity''' |
| | + | !'''Duration of effect (hours)''' |
| | + | |- |
| | + | |'''Hydrocortisone''' |
| | + | |1 |
| | + | |1 |
| | + | |8-12 |
| | + | |- style="background:#F0F8FF; color:black" |
| | + | |'''Cortisone''' |
| | + | |0.8 |
| | + | |0.8 |
| | + | |8-12 |
| | + | |- style="background:#B0E0E6; color:black" |
| | + | |'''Prednisolone''' |
| | + | |4 |
| | + | |0.8 |
| | + | |12-36 |
| | + | |- style="background:#F0F8FF; color:black" |
| | + | |'''Prednisone''' |
| | + | |4 |
| | + | |0.8 |
| | + | |12-36 |
| | + | |- style="background:#B0E0E6; color:black" |
| | + | |'''Methylprednisolone''' |
| | + | |5 |
| | + | |Minimal |
| | + | 12-36 |
| | + | |- style="background:#F0F8FF; color:black" |
| | + | |'''Dexamethasone''' |
| | + | |30 |
| | + | |Minimal |
| | + | |24-28 |
| | + | |- style="background:#B0E0E6; color:black" |
| | + | |'''Betamethasone''' |
| | + | |30 |
| | + | |Minimal |
| | + | |24-48 |
| | + | |- style="background:#F0F8FF; color:black" |
| | + | |'''Fludrocortisone''' |
| | + | |15 |
| | + | |150 |
| | + | |8-12 |
| | + | |} |
| | | | |
| | ==Clinical Uses== | | ==Clinical Uses== |